Related Experiment Video
Updated: Jun 27, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Changes in skin test reactivity among adults with atopic disease: a 3-year prospective study
Nina Aslund1, Simon Francis Thomsen, Ellen Mølgaard
1Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, Denmark.
Background:
Our knowledge about longitudinal predictors of atopy is limited.
Objectives:
To describe changes in skin test reactivity during a 3-year period in a sample of adolescents and adults with atopic disease and to identify factors of importance for these changes.
Methods:
From a sample of 1,186 candidates, ranging in age from 14 to 44 years, who in a screening questionnaire reported symptoms suggestive of respiratory allergic disease, 344 individuals with a positive skin prick test (SPT) result concomitantly with asthma and/or rhinitis were clinically studied on 2 occasions, 3 years apart.
Results:
In total, 134 (39% of the study population) had a different SPT result at follow-up compared with baseline, based on a diagnostic criterion of 3 mm for a positive test result; 77 (22%) developed de novo sensitizations to 1 or more allergens, 45 (13%) had remission of 1 or more sensitizations, and 12 (4%) both gained and lost sensitizations. Female sex (odds ratio = 1.90 [1.02-3.57], P = .04) significantly predicted incidence of 1 or more sensitizations.
Conclusions:
Four of 10 adults with atopic disease will have changes in SPT status during a 3-year period, and most will gain new sensitizations. Women with atopic disease are at increased risk of developing new sensitizations compared with men.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Allergic Reactions
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Asthma III: Clinical Manifestations
